These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23292282)

  • 21. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
    Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
    Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
    Wang K; Li J; Xiong YF; Zeng Z; Zhang X; Li HY
    Sci Rep; 2018 Feb; 8(1):3179. PubMed ID: 29453409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.
    Prat A; Parker JS; Fan C; Cheang MCU; Miller LD; Bergh J; Chia SKL; Bernard PS; Nielsen TO; Ellis MJ; Carey LA; Perou CM
    Ann Oncol; 2012 Nov; 23(11):2866-2873. PubMed ID: 22532584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minireview: nuclear receptors and breast cancer.
    Conzen SD
    Mol Endocrinol; 2008 Oct; 22(10):2215-28. PubMed ID: 18417735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
    Bièche I; Girault I; Urbain E; Tozlu S; Lidereau R
    Breast Cancer Res; 2004; 6(3):R252-63. PubMed ID: 15084249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
    Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
    Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
    Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
    J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.
    Orlando C; Raggi CC; Bianchi S; Distante V; Simi L; Vezzosi V; Gelmini S; Pinzani P; Smith MC; Buonamano A; Lazzeri E; Pazzagli M; Cataliotti L; Maggi M; Serio M
    Endocr Relat Cancer; 2004 Jun; 11(2):323-32. PubMed ID: 15163307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.
    Soleimani Dodaran M; Borgoni S; Sofyalı E; Verschure PJ; Wiemann S; Moerland PD; van Kampen AHC
    BMC Cancer; 2020 Jul; 20(1):676. PubMed ID: 32684154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
    Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
    Horm Cancer; 2012 Aug; 3(4):147-59. PubMed ID: 22476979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
    Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
    Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
    Linardou H; Kalogeras KT; Kronenwett R; Kouvatseas G; Wirtz RM; Zagouri F; Gogas H; Christodoulou C; Koutras AK; Samantas E; Pectasides D; Bafaloukos D; Fountzilas G
    Breast Cancer Res; 2012 Nov; 14(6):R145. PubMed ID: 23146280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.
    Causey MW; Huston LJ; Harold DM; Charaba CJ; Ippolito DL; Hoffer ZS; Brown TA; Stallings JD
    J Surg Res; 2011 Dec; 171(2):615-22. PubMed ID: 20655063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
    Bostner J; Alayev A; Berman AY; Fornander T; Nordenskjöld B; Holz MK; Stål O
    Breast Cancer Res Treat; 2018 Feb; 168(1):17-27. PubMed ID: 29128895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
    Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
    Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.
    Kim JY; Park K; Lee E; Jung HH; Ahn JS; Im YH; Park WY; Park YH
    Oncotarget; 2017 Jan; 8(5):8693-8706. PubMed ID: 28060723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.